Page last updated: 2024-09-05

lapatinib and phenanthrenes

lapatinib has been researched along with phenanthrenes in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (phenanthrenes)	Trials (phenanthrenes)	Recent Studies (post-2010) (phenanthrenes)
1,919	305	1,442	7,618	110	3,211

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, B; Luo, KQ; Wei, N; Yip, WK	1

Other Studies

1 other study(ies) available for lapatinib and phenanthrenes

Article	Year
Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells. Cancer letters, 2020, 10-10, Volume: 490 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Lapatinib; Mice; Mice, Nude; Phenanthrenes; Receptor, ErbB-2; Xenograft Model Antitumor Assays	2020

Article

Year

Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells.

Cancer letters, 2020, 10-10, Volume: 490

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Lapatinib; Mice; Mice, Nude; Phenanthrenes; Receptor, ErbB-2; Xenograft Model Antitumor Assays

2020